Trials
Search / Trial NCT06442176

Choroid In Coronary Artery Disease

Launched by BURSA YÜKSEK İHTISAS EDUCATION AND RESEARCH HOSPITAL · Jun 2, 2024

Trial Information

Current as of February 14, 2025

Completed

Keywords

Coronary Artery Disease Choroid Gensini Score Optical Coherence Tomography

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Normal coronaries at coronary angiography for healthy control group
  • Without any coronary artery disease equivalent diseases such as peripheral artery disease, cerebrovascular disease and stroke for healthy control group
  • Ability to give informed consent for the study
  • Coronary artery disease with stenosis detected in coronary angiogram for coronary artery disease group
  • Exclusion Criteria:
  • High myopia (\> 6D)
  • Cataracts
  • Retinal vascular disease
  • Retinal surgery
  • Retinal dystrophy
  • Laser photocoagulation
  • Intravitreal anti-VEGF treatment
  • Glaucoma
  • Uveitis
  • Retinal disorders (comprising diabetic macular edema, diabetic/hypertensive retinopathy, vein occlusions, retinal dystrophy, epiretinal membrane, vitreomacular traction, age-related macular degeneration)
  • Any systemic diseases
  • Obesity (body-mass index ≥30 kg/m²)

Trial Officials

Hakan Tenekecioglu, MD

Study Director

Balikesir City Hospital

Iskender Kadife, MD

Principal Investigator

Balikesir City Hospital

Erhan Tenekecioglu

Principal Investigator

Saglik Bilimleri Universitesi

About Bursa Yüksek İhtisas Education And Research Hospital

Bursa Yüksek İhtisas Education and Research Hospital is a leading medical institution in Turkey, dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on education, the hospital provides cutting-edge training for healthcare professionals while fostering a collaborative environment for scientific inquiry. Its commitment to patient-centered care and rigorous research standards positions it as a key player in the development of new therapies and medical advancements. By actively engaging in clinical trials, Bursa Yüksek İhtisas aims to contribute to the global healthcare landscape and improve treatment outcomes for diverse patient populations.

Locations

Balıkesir, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0